USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Small Pharma Ltd

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2022–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Small ranks #30,173 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#30,173
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.9/100)
13.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30173 · Foreign Corporation #30,173 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,173/49,997
  • PHOTO-FINISH Sky Medical Technology
  • CPC-NARROW C07D · 5 areas
  • INNOV-PAR 43.9/100
  • CLAIMS-RICH 13.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2023 · 2y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Sky Medical Technology, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Small’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Small

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Small's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Small?

Each dot is one of Small’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Small’s own 13.3 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Small vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 0510152025 Granted patents (volume) Avg claims / patent Sky Medical Technology, Ltd. - 9, 13.33Sky Medical Techn…Skybest Electric Appliance (Suzhou) Co., Ltd. - 9, 12.56Skybest Electric…Slice Technologies, Inc. - 9, 19.67SliceSlumberkins Inc. - 9, 1SlumberkinsSmart Electronic Industrial (Dongguan) Co., Limited - 9, 11.89Smart Industrial…Smarte Carte, Inc. - 9, 17.89Smarte CarteSmartsafe Console, LLC - 9, 7.22Smartsafe ConsoleSmileSonica, Inc. - 9, 13.56SmilesonicaSmall Pharma Ltd - 9, 13.33Small Pharma
Small vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Small's grants concentrate

Small Pharma Ltd is a focused PatentsView assignee: 5 CPC subclasses with 88.9% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2023 (6 grants) versus a trough of 3 in 2022. By volume, Small sits between Sky Medical Technology, Ltd. and SmileSonica, Inc..

Small's three-year grant acceleration

Small Pharma Ltd shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Small's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Small holds 9 patents at rank #30,200, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Small

By rank, the assignees closest to #30,200 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Small's primary technology class.

Small's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

234567 20222023 6
USPTO utility patent grants by year · 2022–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Small Pharma Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 3 33.3%
2023 6 66.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Small Pharma Ltd's patent record in context - here's where to go next.

  • Small Pharma Ltd's lead technology class is C07D (Heterocyclic Compounds), 88.9% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #30,173 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Small Pharma Ltd against Sky Medical Technology, Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.